Recombinant human insulin manufacturer and contract biotech services provider
Bioton is a Polish biotech manufacturer focused on recombinant human insulin, operating as one of the world's top eight commercial producers in this category. The company's tech stack is SAP-heavy (PP/QM, WMS, BW, MM, SD modules) with Power BI analytics—typical of regulated manufacturing operations managing supply chain and quality workflows at scale. Current hiring focuses on manufacturing and engineering roles, with active projects centered on WMS implementation and bioprocess optimization, signaling operational scaling and compliance-driven process work.
Bioton S.A., founded in 1989 and headquartered in Ożarów Mazowiecki, Poland, manufactures recombinant human insulin in both API and finished forms (cartridges and vials). The company holds a dominant position on the Polish market and ranks among the world's top eight commercial insulin manufacturers. Beyond insulin, Bioton offers CMO/CDMO contract services, quality control testing, and a range of specialty foods for medical purposes. Operations are built on Quality by Design principles and cGMP-compliant processes. The company employs 201–500 people and maintains active R&D, manufacturing, and supply-chain functions.
Bioton runs SAP enterprise software across manufacturing (PP/QM, WMS, MM, SD modules), materials planning, and warehouse management, paired with Power BI for analytics and Microsoft Office productivity tools.
Current projects include WMS implementation, bioprocess optimization, R&D scaling and technology transfer, process stabilization, and continuous improvement—aligned with GMP compliance and regulatory demands.
Other companies in the same industry, closest in size